首页|高强度聚焦超声联合温经通阻方治疗子宫腺肌病的疗效观察

高强度聚焦超声联合温经通阻方治疗子宫腺肌病的疗效观察

扫码查看
目的:探讨高强度聚焦超声(HIFU)联合温经通阻方治疗子宫腺肌病的临床疗效及安全性.方法:收集符合纳入标准的寒凝血瘀型子宫腺肌病患者66例,随机分为西药组和联合组每组33例.西药组在行HIFU治疗后予促性腺激素释放激素激动剂(GnRH-a)治疗,联合组在西药组基础上予温经通阻方保留灌肠,比较两组患者治疗前后子宫及病灶体积、痛经评分、月经量评分、中医证候评分,同时记录两组治疗时及治疗后6个月内累计出现的不良反应.结果:两组治疗后3个月及6个月子宫、病灶体积与治疗前比较明显缩小,差异有统计学意义(P<0.05);治疗后6个月子宫、病灶体积比治疗后3个月明显缩小,差异有统计学意义(P<0.05).组间比较,治疗后3个月及6个月联合组子宫与病灶体积缩小率均高于西药组,但差异无统计学意义(P>0.05).两组治疗后6个月痛经评分、月经量评分、中医证候评分均较治疗前明显降低,差异有统计学意义(P<0.05).联合组治疗后6个月痛经评分、月经量评分、中医证候评分低于西药组,差异有统计学意义(P<0.05).中医证候改善有效率联合组达96.66%,西药组达86.66%,两组总有效率比较,差异有统计学意义(P<0.05);两组患者HIFU术中出现的不良反应发生率相当,差异无统计学意义(P>0.05);西药组治疗后6个月累计出现的低雌激素反应发生率高于联合组,差异有统计学意义(P<0.05).结论:HIFU+GnRH-a+温经通阻方治疗子宫腺肌病疗效确切,安全性好,在缓解患者痛经症状、减少月经量及改善中医证候方面疗效显著,不良反应发生低,值得临床推广应用.
Observation on the curative effect of high intensity focused ultrasound combined with Wenjing Tongzu Formula in the treatment of adenomyosis
Objective:To investigate the clinical efficacy and safety of high intensity focused ultrasound(HIFU)com-bined with drugs in the treatment of adenomyosis.Methods:A total of 66 adenomyosis patients with cold-coagulation and blood-stasis syndrome who met the inclusion criteria were collected and randomly divided into western medicine group and combined treatment group,33 cases in each group.Patients in the western medicine group were treated with gonadotropin-releasing hormone agonist GnRH-a after HIFU treatment,and patients in the combined treatment group were treated with retention enema with Wenjing Tongzu Formula on the basis of western medicine group.The uterus and lesion volume,dys-menorrhea score,menstrual volume score and TCM syndrome score of the two groups were compared before and after treat-ment,and the accumulated adverse reactions during treatment and within 6 months after treatment were recorded.Results:The volumes of uterus and lesion in both groups were significantly reduced at 3 and 6 months after treatment,and the differ-ence was statistically significant(P<0.05).The volumes of uterus and lesion at 6 months after treatment were significantly smaller than that at 3 months after treatment,and the difference was statistically significant(P<0.05).After 3 months and 6 months of treatment,the reduction rate of uterus and lesion volumes in the combined group was higher than that in the west-ern medicine group,but the difference was not statistically significant(P>0.05).Dysmenorrhea scores,menstrual volume scores and TCM syndrome scores of the two groups were significantly lower 6 months after treatment than those before treat-ment,and the differences were statistically significant(P<0.05).The reduction rate of dysmenorrhea score,menstrual vol-ume score and TCM syndrome score 6 months after treatment in combined treatment group was higher than that in western medicine group,and the difference was statistically significant(P<0.05).The improvement efficiency rate of TCM syndrome was 96.66%in the combined treatment group and 86.66%in the western medicine group.Comparison of the total curative effect of TCM between the two groups showed statistically significant difference(P<0.05).The incidence of adverse reactions during HIFU operation was similar between the two groups,with no statistical significance(P>0.05).After 6 months of treatment,the cumulative incidence of low estrogen reaction in the western medicine group was higher than that in the com-bined treatment group,and the difference was statistically significant(P<0.05).Conclusion:HIFU+GnRH-a+Wenjing Tongzu Formula has definite efficacy and good safety in the treatment of adenomyosis.It has significant efficacy in relieving dysmenorrhea symptoms,reducing menstrual volume and improving TCM syndromes,and has low adverse reactions,which is worthy of clinical promotion and application.

adenomyosisHIFUgonadotropin-releasing hormone agonist GnRH-aWenjing Tongzu Formula

易华娅、刘璇、刘小古、曾莉、张向华、胡成凤

展开 >

贵州中医药大学第二附属医院,贵州 贵阳 550001

子宫腺肌病 高强度聚焦超声 促性腺激素释放激素激动剂 温经通阻方

贵阳中医药大学科研项目

贵中医科院内[2018]34号

2024

山西中医药大学学报

山西中医药大学学报

ISSN:
年,卷(期):2024.25(6)
  • 9